Your Health 5-13-13 New COPD treatment

{} {} The U.S. Food and Drug Administration has approved a new drug to treat a lung disease that is the third leading cause of death among Americans.{}{}{}{}{}{} The agency gave the green light for the drug, Breo Ellipta to treat chronic obstructive pulmonary disease, also known as COPD.{}{}{} It's approved to for use among patients with COPD, including chronic bronchitis and/or emphysema.{}{}{}{}{}{} The FDA says the drug works by decreasing airflow in the lungs and helping muscles around the airways of the lungs stay relaxed in order to increase airflow.{}{}{}{} Serious side effects associated with the drug include increased risks of pneumonia and bone fractures. {}{}{}{} The most common side effects include inflammation of the nasal passage, upper respiratory tract infection, and headache.